Description

Tesamorelin is a stabilized synthetic analogue of growth hormone-releasing hormone engineered to stimulate endogenous growth hormone secretion through receptor-mediated pituitary signaling pathways within controlled laboratory environments. Its modified peptide structure has generated significant interest in studies involving endocrine regulation, metabolic signaling, and peptide-driven hormonal communication processes. Researchers investigate Tesamorelin for its interaction with biological pathways associated with IGF-1 activity, adipose tissue signaling, nutrient-related metabolic mechanisms, and receptor-mediated peptide responses. The compound is frequently utilized in laboratory investigations examining growth hormone secretion dynamics, endocrine pathway modulation, and metabolic communication across advanced experimental research models. Tesamorelin is also studied for its structural stability and prolonged biological activity profile when examining sustained peptide signaling mechanisms under controlled conditions. Due to its receptor-targeted endocrine activity, it remains widely utilized in peptide signaling studies and metabolic pathway investigations requiring long-acting growth hormone-releasing hormone analogues. Each vial is supplied as research-grade lyophilized material manufactured under controlled laboratory standards with verified purity and third-party analytical testing protocols supporting consistency, structural integrity, and reliability in scientific peptide research applications.

Molecular Formula: C₂₂₁H₃₆₆N₆₈O₆₇S
Molecular Weight: 5135.77 g/mol
Storage: Store lyophilized at −20°C under sterile laboratory conditions

FOR RESEARCH USE ONLY